No Data
No Data
Mira Pharmaceuticals Analyst Ratings
Mira Pharmaceuticals Initiated With a Buy at Rodman & Renshaw
Express News | Mira Pharmaceuticals - May Offer,Sell Shares of Common Stock of up to $75 Mln From Time to Time
Why Mira Shares Are Trading Higher Today
Express News | MIRA Pharmaceuticals Shares Are Trading Higher After the Company Announced New Preclinical Data for Ketamir-2,
Reported Earlier: MIRA Pharmaceuticals To Present New Preclinical Data Showing 100% Reversal Of Neuropathic Pain For Ketamir-2 At 18th Annual Pain Therapeutics Summit In Boston On October 28-29, 2024
No Data
No Data